These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 26340912)
1. Participant selection for preventive Regenerative Medicine trials: ethical challenges of selecting individuals at risk. Niemansburg SL; Habets MG; Dhert WJ; van Delden JJ; Bredenoord AL J Med Ethics; 2015 Nov; 41(11):914-6. PubMed ID: 26340912 [TBL] [Abstract][Full Text] [Related]
2. Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials. de Windt TS; Niemansburg SL; Vonk LA; van Delden JM; Roes KCB; Dhert WJA; Saris DBF; Bredenoord AL Osteoarthritis Cartilage; 2019 Jan; 27(1):34-40. PubMed ID: 30243948 [TBL] [Abstract][Full Text] [Related]
3. Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients. Niemansburg SL; van Delden JJ; Dhert WJ; Bredenoord AL Regen Med; 2013 Jan; 8(1):65-73. PubMed ID: 23259806 [TBL] [Abstract][Full Text] [Related]
4. Ethical implications of regenerative medicine in orthopedics: an empirical study with surgeons and scientists in the field. Niemansburg SL; van Delden JJ; Oner FC; Dhert WJ; Bredenoord AL Spine J; 2014 Jun; 14(6):1029-35. PubMed ID: 24184644 [TBL] [Abstract][Full Text] [Related]
5. Ethical reflections on clinical trials with human tissue engineered products. Trommelmans L; Selling J; Dierickx K J Med Ethics; 2008 Sep; 34(9):e1. PubMed ID: 18757609 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials of drugs and vaccines among the desperately poor in poor nations: ethical challenges and ethical solutions. Caplan AL Clin Pharmacol Ther; 2010 Nov; 88(5):583-4. PubMed ID: 20959841 [TBL] [Abstract][Full Text] [Related]
7. Improving subject recruitment by maintaining truly informed consent: a practical benefit of disclosing adverse clinical trial results. Shah KR; Batzer FR Am J Bioeth; 2009 Aug; 9(8):36-7. PubMed ID: 19998157 [No Abstract] [Full Text] [Related]
8. Ethical pitfalls in neonatal comparative effectiveness trials. Modi N Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328 [TBL] [Abstract][Full Text] [Related]
10. Preventive ethics for including women of childbearing potential in clinical trials. McCullough LB; Coverdale JH; Chervenak FA Am J Obstet Gynecol; 2006 May; 194(5):1221-7. PubMed ID: 16647904 [TBL] [Abstract][Full Text] [Related]
11. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials. Vanderpool HY Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766 [TBL] [Abstract][Full Text] [Related]
12. From protection to entitlement: selecting research subjects for early phase clinical trials involving breakthrough therapies. Jecker NS; Wightman AG; Rosenberg AR; Diekema DS J Med Ethics; 2017 Jun; 43(6):391-400. PubMed ID: 28408724 [TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
14. Informed consent for inclusion into clinical trials: a serious subject to note in the developing world. Izadi M; Fazel M; Nasiri-Vanashi T; Saadat SH; Taheri S Arab J Nephrol Transplant; 2012 May; 5(2):97-100. PubMed ID: 22612196 [TBL] [Abstract][Full Text] [Related]
15. Microbicide research in developing countries: have we given the ethical concerns due consideration? Moodley K BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834 [TBL] [Abstract][Full Text] [Related]
16. Money and distorted ethical judgments about research: ethical assessment of the TeGenero TGN1412 trial. Emanuel EJ; Miller FG Am J Bioeth; 2007 Feb; 7(2):76-81. PubMed ID: 17366206 [TBL] [Abstract][Full Text] [Related]
17. Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease Research. Milne R; Bunnik E; Tromp K; Bemelmans S; Badger S; Gove D; Maman M; Schermer M; Truyen L; Brayne C; Richard E J Prev Alzheimers Dis; 2017; 4(2):125-131. PubMed ID: 29186282 [TBL] [Abstract][Full Text] [Related]
18. Disclosure of risks and uncertainties are especially vital in light of regenerative medicine. Niemansburg SL; Habets MG; van Delden JJ; Bredenoord AL Am J Bioeth; 2014; 14(4):14-6. PubMed ID: 24730482 [No Abstract] [Full Text] [Related]
19. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa. Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900 [TBL] [Abstract][Full Text] [Related]